PARDRIDGE; William M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PARDRIDGE; William M..The latest application filed is for "methods and compositions for increasing n-acetylglucosaminidase activity in the cns".

Company Profile

10.42.47

PARDRIDGE; William M. - Pacific Palisades CA
- Pacific Palisades CA US
Pardridge; William M. - Los Angeles CA
Pardridge; William M. - Van Nuys CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Increasing N-acetylglucosaminidase Activity In The Cns App 20220127369 - PARDRIDGE; William M. ; et al.	2022-04-28
Methods And Compositions For Increasing Galactosidase Beta-1 Activity In The Cns App 20210403584 - PARDRIDGE; William M. ; et al.	2021-12-30
Macromolecular compositions that cross the blood-brain barrier and methods of use thereof Grant 11,155,631 - Pardridge , et al. October 26, 2	2021-10-26
Methods And Compositions For Increasing Iduronate 2-sulfatase Activity In The Cns App 20210253681 - PARDRIDGE; William M. ; et al.	2021-08-19
Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS Grant 11,028,156 - Pardridge , et al. June 8, 2	2021-06-08
Compositions and methods related to structures that cross the blood brain barrier Grant 10,906,981 - Pardridge , et al. February 2, 2	2021-02-02
Methods And Compositions For Increasing N-acetylglucosaminidase Activity In The Cns App 20210002379 - PARDRIDGE; William M. ; et al.	2021-01-07
Methods And Compositions For Increasing Enzyme Activity In The Cns App 20200308292 - PARDRIDGE; William M. ; et al.	2020-10-01
Fusion Proteins For Delivery Of Gdnf To The Cns App 20200254113 - Kind Code	2020-08-13
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU Grant 10,538,589 - Pardridge , et al. Ja	2020-01-21
Methods And Compositions For Increasing Alpha-l-iduronidase Activity In The Cns App 20190389975 - Pardridge; William M. ; et al.	2019-12-26
Methods And Compositions For Increasing Iduronate 2-sulfatase Activity In The Cns App 20190185551 - Pardridge; William M. ; et al.	2019-06-20
Methods and compositions for increasing .alpha.-L-iduronidase activity in the CNS Grant 10,202,467 - Pardridge , et al. Feb	2019-02-12
Macromolecular compositions that cross the blood-brain barrier and methods of use thereof Grant 10,144,783 - Pardridge , et al. De	2018-12-04
Methods And Compositions For Increasing Iduronate 2-sulfatase Activity In The Cns App 20180251535 - Pardridge; William M. ; et al.	2018-09-06
Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS Grant 10,011,651 - Pardridge , et al. July 3, 2	2018-07-03
Methods and compositions for increasing arylsulfatase A activity in the CNS Grant 9,975,955 - Pardridge , et al. May 22, 2	2018-05-22
Methods And Compositions For Increasing Alpha-l-iduronidase Activity In The Cns App 20170114152 - Pardridge; William M. ; et al.	2017-04-27
Methods and compositions for increasing .alpha.-L-iduronidase activity in the CNS Grant 9,567,400 - Pardridge , et al. February 14, 2	2017-02-14
Compositions and methods for blood-brain barrier delivery of IgG-decoy receptor fusion proteins Grant 9,533,055 - Pardridge , et al. January 3, 2	2017-01-03
Methods And Compositions For Increasing N-acetylglucosaminidase Activity In The Cns App 20160208006 - Pardridge; William M. ; et al.	2016-07-21
Compositions And Methods Related To Structures That Cross The Blood Brain Barrier App 20160152719 - Pardridge; William M. ; et al.	2016-06-02
Methods And Compositions For Increasing Alpha-l-iduronidase Activity In The Cns App 20150299328 - Pardridge; William M. ; et al.	2015-10-22
Macromolecular Compositions That Cross The Blood-brain Barrier And Methods Of Use Thereof App 20150203586 - PARDRIDGE; William M. ; et al.	2015-07-23
Methods and compositions for increasing .alpha.-L-iduronidase activity in the CNS Grant 8,974,791 - Pardridge , et al. March 10, 2	2015-03-10
Methods And Compositions For Increasing Arylsulfatase A Activity In The Cns App 20150064184 - PARDRIDGE; William M. ; et al.	2015-03-05
Methods And Compositions For Increasing Enzyme Activity In The Cns App 20150023956 - PARDRIDGE; William M. ; et al.	2015-01-22
Methods And Compositions For Increasing Iduronate 2-sulfatase Activity In The Cns App 20150004160 - Pardridge; William M. ; et al.	2015-01-01
Methods and compositions for increasing arylsulfatase A activity in the CNS Grant 08920801 -	2014-12-30
Methods and compositions for increasing arylsulfatase A activity in the CNS Grant 8,920,801 - Pardridge , et al. December 30, 2	2014-12-30
Delivery of pharmaceutical agents via the human insulin receptor Grant 8,858,950 - Pardridge , et al. October 14, 2	2014-10-14
Methods And Compositions For Increasing Arylsulfatase A Activity In The Cns App 20140294822 - PARDRIDGE; William M. ; et al.	2014-10-02
Macromolecular Compositions That Cross The Blood-brain Barrier And Methods Of Use Thereof App 20140288273 - PARDRIDGE; William M. ; et al.	2014-09-25
Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS Grant 8,834,874 - Pardridge , et al. September 16, 2	2014-09-16
Fusion Proteins For Delivery Of Gdnf To The Cns App 20140193409 - PARDRIDGE; William M. ; et al.	2014-07-10
Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns Grant 8,759,297 - Pardridge , et al. June 24, 2	2014-06-24
Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions Grant 8,753,610 - Pardridge , et al. June 17, 2	2014-06-17
Fusion proteins for delivery of GDNF to the CNS Grant 8,741,260 - Pardridge , et al. June 3, 2	2014-06-03
Methods and compositions for increasing arylsulfatase A activity in the CNS Grant 8,715,661 - Pardridge , et al. May 6, 2	2014-05-06
Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS App 20130287773 - PARDRIDGE; William M. ; et al.	2013-10-31
Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions Grant 8,497,246 - Pardridge , et al. July 30, 2	2013-07-30
Methods and compositions for increasing arylsulfatase A activity in the CNS Grant 8,486,399 - Pardridge , et al. July 16, 2	2013-07-16
Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS App 20130142794 - Pardridge; William M. ; et al.	2013-06-06
COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF lgG-DECOY RECEPTOR FUSION PROTEINS App 20120269807 - Pardridge; William M. ; et al.	2012-10-25
Fusion proteins for blood-brain barrier delivery Grant 8,142,781 - Pardridge , et al. March 27, 2	2012-03-27
Fusion proteins for delivery of erythropoietin to the CNS Grant 8,124,095 - Pardridge , et al. February 28, 2	2012-02-28
Nucleic acids encoding and methods of producing fusion proteins Grant 8,053,569 - Pardridge , et al. November 8, 2	2011-11-08
Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS App 20110110935 - Pardridge; William M. ; et al.	2011-05-12
Macromolecular Compositions That Cross The Blood-brain Barrier And Methods Of Use Thereof App 20100290985 - Pardridge; William M. ; et al.	2010-11-18
Fusion Proteins For Delivery Of Erythropoietin To The Cns App 20100261647 - Pardridge; William M. ; et al.	2010-10-14
Fusion antibodies that cross the blood-brain barrier in both directions Grant 7,741,446 - Pardridge , et al. June 22, 2	2010-06-22
Compositions And Methods For Blood-brain Barrier Delivery Of Organophosphatases App 20100098693 - Pardridge; William M. ; et al.	2010-04-22
Compositions And Methods For Blood-brain Barrier Delivery In The Mouse App 20100077498 - Pardridge; William M. ; et al.	2010-03-25
Fusion Proteins For Delivery Of Gdnf To The Cns App 20090156498 - Pardridge; William M. ; et al.	2009-06-18
Delivery of pharmaceutical agents via the human insulin receptor App 20090068206 - Pardridge; William M. ; et al.	2009-03-12
Methods And Compositions For Increasing Alpha-l-iduronidase Activity In The Cns App 20090053219 - Pardridge; William M. ; et al.	2009-02-26
Macromolecular Compositions that Cross the Blood-Brain Barrier and Methods of Use Thereof App 20080170994 - Pardridge; William M. ; et al.	2008-07-17
Methods for Diagnosing and Treating CNS Disorders by Trans-Blood-Brain Barrier Delivery of Protein Compositions App 20080171055 - Pardridge; William M. ; et al.	2008-07-17
Genetically Encoded Multifunctional Compositions Bidrectionally Transported Between Peripheral Blood and the CNS App 20080152645 - Pardridge; William M. ; et al.	2008-06-26
Transport of basic fibroblast growth factor across the blood brain barrier App 20080154022 - Wu; Dafang ; et al.	2008-06-26
Delivery of pharmaceutical agents via the human insulin receptor Grant 7,388,079 - Pardridge , et al. June 17, 2	2008-06-17
Delivery of pharmaceutical agents via the human insulin receptor App 20080051564 - Pardridge; William M. ; et al.	2008-02-28
Nucleic acids encoding and methods of producing fusion proteins App 20070082380 - Pardridge; William M. ; et al.	2007-04-12
Fusion proteins for blood-brain barrier delivery App 20070081992 - Pardridge; William M. ; et al.	2007-04-12
Non-invasive gene targeting to ocular cells Grant 7,090,864 - Pardridge August 15, 2	2006-08-15
Non-invasive gene targeting to ocular cells App 20060105982 - Pardridge; William M.	2006-05-18
Delivery of genes encoding short hairpin RNA using receptor-specific nanocontainers App 20050202075 - Pardridge, William M. ; et al.	2005-09-15
Delivery of enzymes to the brain App 20050142141 - Pardridge, William M.	2005-06-30
Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery App 20050085419 - Morrison, Sherie L. ; et al.	2005-04-21
Immunonanoparticles App 20050042298 - Pardridge, William M. ; et al.	2005-02-24
Delivery of pharmaceutical agents via the human insulin receptor App 20040101904 - Pardridge, William M. ; et al.	2004-05-27
Transport of basic fibroblast growth factor across the blood brain barrier App 20040102369 - Wu, Dafang ; et al.	2004-05-27
Non-invasive gene targeting to ocular cells App 20020054902 - Pardridge, William M.	2002-05-09
Non-invasive gene targeting to the brain Grant 6,372,250 - Pardridge April 16, 2	2002-04-16
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology Grant 6,287,792 - Pardridge , et al. September 11, 2	2001-09-11
Method for enhancing antibody transport through capillary barriers Grant 5,130,129 - Pardridge * July 14, 1	1992-07-14
Cationized antibodies for delivery through the blood-brain barrier Grant 5,004,697 - Pardridge April 2, 1	1991-04-02
Capillary depletion method for quantifying transcytosis through the blood-brain barrier Grant 4,992,255 - Pardridge February 12, 1	1991-02-12
Chimeric peptides for neuropeptide delivery through the blood-brain barrier Grant 4,902,505 - Pardridge , et al. February 20, 1	1990-02-20
Chimeric peptides for neuropeptide delivery through the blood-brain barrier Grant 4,801,575 - Pardridge January 31, 1	1989-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.